This is an expanded access use study. Safety data will be collected from participants.
Study Type
EXPANDED_ACCESS
The schedule for vaccination will be weeks 1, 5, 9, 13, 17, and 21. All vaccines will occur within +/- 1 week with at least 3 weeks between vaccines.
* Ichor Medical Systems * All study injections will be given intramuscularly using an integrated electroporation device
Washington University School of Medicine
St Louis, Missouri, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.